2013-2028 Report on Global CD40 Ligand Market by Player, Region, Type, Application and Sales Channel

Published: Mar, 2019 | Pages: 107 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global CD40 Ligand market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for CD40 Ligand from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the CD40 Ligand market.

Leading players of CD40 Ligand including:
    Biogen, Inc.
    Bristol-Myers Squibb Company
    eTheRNA Immunotherapies NV
    ImmuNext, Inc.
    Juno Therapeutics Inc.
    MedImmune, LLC
    Targovax AS
    XL-protein GmbH

Market split by Type, can be divided into:
    ISF-35
    LOAd-700
    MEDI-4920
    MegaCD40L
    Others

Market split by Application, can be divided into:
    Hepatitis B
    Bladder Cancer
    Liver Cancer
    Ovarian Cancer
    Others

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 CD40 Ligand Market Overview
    1.1 CD40 Ligand Definition
    1.2 Global CD40 Ligand Market Size Status and Outlook (2013-2028)
    1.3 Global CD40 Ligand Market Size Comparison by Region (2013-2028)
    1.4 Global CD40 Ligand Market Size Comparison by Type (2013-2028)
    1.5 Global CD40 Ligand Market Size Comparison by Application (2013-2028)
    1.6 Global CD40 Ligand Market Size Comparison by Sales Channel (2013-2028)
    1.7 CD40 Ligand Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 CD40 Ligand Market Segment Analysis by Player
    2.1 Global CD40 Ligand Sales and Market Share by Player (2016-2018)
    2.2 Global CD40 Ligand Revenue and Market Share by Player (2016-2018)
    2.3 Global CD40 Ligand Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 CD40 Ligand Market Segment Analysis by Type
    3.1 Global CD40 Ligand Market by Type
        3.1.1 ISF-35
        3.1.2 LOAd-700
        3.1.3 MEDI-4920
        3.1.4 MegaCD40L
        3.1.5 Others
    3.2 Global CD40 Ligand Sales and Market Share by Type (2013-2018)
    3.3 Global CD40 Ligand Revenue and Market Share by Type (2013-2018)
    3.4 Global CD40 Ligand Average Price by Type (2013-2018)
    3.5 Leading Players of CD40 Ligand by Type in 2017
    3.6 Conclusion of Segment by Type
Chapter 4 CD40 Ligand Market Segment Analysis by Application
    4.1 Global CD40 Ligand Market by Application
        4.1.1 Hepatitis B
        4.1.2 Bladder Cancer
        4.1.3 Liver Cancer
        4.1.4 Ovarian Cancer
        4.1.5 Others
    4.2 Global CD40 Ligand Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of CD40 Ligand by Application in 2017
    4.4 Conclusion of Segment by Application
Chapter 5 CD40 Ligand Market Segment Analysis by Sales Channel
    5.1 Global CD40 Ligand Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global CD40 Ligand Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of CD40 Ligand by Sales Channel in 2017
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 CD40 Ligand Market Segment Analysis by Region
    6.1 Global CD40 Ligand Market Size and CAGR by Region (2013-2028)
    6.2 Global CD40 Ligand Sales and Market Share by Region (2013-2018)
    6.3 Global CD40 Ligand Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America CD40 Ligand Market Share by Type
        6.4.3 North America CD40 Ligand Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe CD40 Ligand Market Share by Type
        6.5.3 Europe CD40 Ligand Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific CD40 Ligand Market Share by Type
        6.6.3 Asia-Pacific CD40 Ligand Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America CD40 Ligand Market Share by Type in 2017
        6.7.3 South America CD40 Ligand Market Share by Application in 2017
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa CD40 Ligand Market Share by Type
        6.8.3 Middle East & Africa CD40 Ligand Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading CD40 Ligand Players
    7.1 Biogen, Inc.
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Bristol-Myers Squibb Company
    7.3 eTheRNA Immunotherapies NV
    7.4 ImmuNext, Inc.
    7.5 Juno Therapeutics Inc.
    7.6 MedImmune, LLC
    7.7 Targovax AS
    7.8 XL-protein GmbH
Chapter 8 Upstream and Downstream Analysis of CD40 Ligand
    8.1 Industrial Chain of CD40 Ligand
    8.2 Upstream of CD40 Ligand
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of CD40 Ligand
        8.3.1 Leading Distributors/Dealers of CD40 Ligand
        8.3.2 Leading Consumers of CD40 Ligand
Chapter 9 Development Trend of CD40 Ligand (2018-2028)
    9.1 Global CD40 Ligand Market Size (Sales and Revenue) Forecast (2018-2028)
    9.2 Global CD40 Ligand Market Size and CAGR Forecast by Region (2018-2028)
    9.3 Global CD40 Ligand Market Size and CAGR Forecast by Type (2018-2028)
    9.4 Global CD40 Ligand Market Size and CAGR Forecast by Application (2018-2028)
    9.5 Global CD40 Ligand Market Size Forecast by Sales Channel (2018-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure CD40 Ligand Example
    Figure Global CD40 Ligand Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global CD40 Ligand Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global CD40 Ligand Sales Comparison by Type (2013-2028)
    Figure Global CD40 Ligand Sales Comparison by Application (2013-2028)
    Figure Global CD40 Ligand Sales Comparison by Sales Channel (2013-2028)
    Table Global CD40 Ligand Sales by Player (2016-2018)
    Table Global CD40 Ligand Sales Market Share by Player (2016-2018)
    Figure Global CD40 Ligand Sales Market Share by Player in 2017
    Table Global CD40 Ligand Revenue (Million $) by Player (2016-2018)
    Table Global CD40 Ligand Revenue Market Share by Player (2016-2018)
    Figure Global CD40 Ligand Revenue Market Share by Player in 2017
    Table Global CD40 Ligand Average Price by Player (2016-2018)
    Figure Global CD40 Ligand Average Price by Player in 2017
    Figure Global CD40 Ligand Players Competition Situation - Top 5 Players' Revenue Market Share in 2017
    Figure Global CD40 Ligand Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of ISF-35
    Figure Global ISF-35 Sales and Growth Rate (2013-2018)
    Figure Example of LOAd-700
    Figure Global LOAd-700 Sales and Growth Rate (2013-2018)
    Figure Example of MEDI-4920
    Figure Global MEDI-4920 Sales and Growth Rate (2013-2018)
    Figure Example of MegaCD40L
    Figure Global MegaCD40L Sales and Growth Rate (2013-2018)
    Figure Example of Others
    Figure Global Others Sales and Growth Rate (2013-2018)
    Table Global CD40 Ligand Sales by Type (2013-2018)
    Table Global CD40 Ligand Sales Market Share by Type (2013-2018)
    Figure Global CD40 Ligand Sales Market Share by Type in 2017
    Table Global CD40 Ligand Revenue (Million $) by Type (2013-2018)
    Table Global CD40 Ligand Revenue Market Share by Type (2013-2018)
    Figure Global CD40 Ligand Revenue Market Share by Type in 2017
    Table Global CD40 Ligand Average Price by Type (2013-2018)
    Figure Global CD40 Ligand Average Price by Type in 2017
    Table Leading Players of CD40 Ligand by Type in 2017
    Figure Example of Hepatitis B
    Figure Global CD40 Ligand for Hepatitis B Sales and Growth Rate (2013-2018)
    Figure Example of Bladder Cancer
    Figure Global CD40 Ligand for Bladder Cancer Sales and Growth Rate (2013-2018)
    Figure Example of Liver Cancer
    Figure Global CD40 Ligand for Liver Cancer Sales and Growth Rate (2013-2018)
    Figure Example of Ovarian Cancer
    Figure Global CD40 Ligand for Ovarian Cancer Sales and Growth Rate (2013-2018)
    Figure Example of Others
    Figure Global CD40 Ligand for Others Sales and Growth Rate (2013-2018)
    Table Global CD40 Ligand Sales by Application (2013-2018)
    Table Global CD40 Ligand Sales Market Share by Application (2013-2018)
    Figure Global CD40 Ligand Sales Market Share by Application in 2017
    Table Leading Consumers of CD40 Ligand by Application in 2017
    Figure Example of Direct Channel
    Figure Global CD40 Ligand for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global CD40 Ligand for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global CD40 Ligand Sales by Sales Channel (2013-2018)
    Table Global CD40 Ligand Sales Market Share by Sales Channel (2013-2018)
    Figure Global CD40 Ligand Sales Market Share by Sales Channel in 2017
    Table Leading Distributors/Dealers of CD40 Ligand by Sales Channel in 2017
    Table Global CD40 Ligand Market Size and CAGR by Region (2013-2028)
    Table Global CD40 Ligand Sales by Region (2013-2018)
    Table Global CD40 Ligand Sales Market Share by Region (2013-2018)
    Figure Global CD40 Ligand Sales Market Share by Region in 2017
    Table Global CD40 Ligand Revenue (Million $) by Region (2013-2018)
    Table Global CD40 Ligand Revenue Market Share by Region (2013-2018)
    Figure Global CD40 Ligand Revenue Market Share by Region in 2017
    Table North America CD40 Ligand Sales by Country (2013-2018)
    Figure North America CD40 Ligand Sales Market Share by Country (2013-2018)
    Table North America CD40 Ligand Revenue by Country (2013-2018)
    Figure North America CD40 Ligand Revenue Market Share by Country (2013-2018)
    Figure North America CD40 Ligand Sales Market Share by Type in 2017
    Figure North America CD40 Ligand Sales Market Share by Application in 2017
    Figure United States CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure United States CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Canada CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Mexico CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe CD40 Ligand Sales by Country (2013-2018)
    Figure Europe CD40 Ligand Sales Market Share by Country (2013-2018)
    Table Europe CD40 Ligand Revenue by Country (2013-2018)
    Figure Europe CD40 Ligand Revenue Market Share by Country (2013-2018)
    Figure Europe CD40 Ligand Sales Market Share by Type in 2017
    Figure Europe CD40 Ligand Sales Market Share by Application in 2017
    Figure Germany CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Germany CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure UK CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure France CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure France CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Italy CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Russia CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Spain CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific CD40 Ligand Sales by Country (2013-2018)
    Figure Asia-Pacific CD40 Ligand Sales Market Share by Country (2013-2018)
    Table Asia-Pacific CD40 Ligand Revenue by Country (2013-2018)
    Figure Asia-Pacific CD40 Ligand Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific CD40 Ligand Sales Market Share by Type in 2017
    Figure Asia-Pacific CD40 Ligand Sales Market Share by Application in 2017
    Figure China CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure China CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Japan CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Korea CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure India CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure India CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Southeast Asia CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Australia CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Table South America CD40 Ligand Sales by Country (2013-2018)
    Figure South America CD40 Ligand Sales Market Share by Country (2013-2018)
    Table South America CD40 Ligand Revenue by Country (2013-2018)
    Figure South America CD40 Ligand Revenue Market Share by Country (2013-2018)
    Figure South America CD40 Ligand Sales Market Share by Type in 2017
    Figure South America CD40 Ligand Sales Market Share by Application in 2017
    Figure Brazil CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Brazil CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Argentina CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Colombia CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Chile CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa CD40 Ligand Sales by Country (2013-2018)
    Figure Middle East & Africa CD40 Ligand Sales Market Share by Country (2013-2018)
    Table Middle East & Africa CD40 Ligand Revenue by Country (2013-2018)
    Figure Middle East & Africa CD40 Ligand Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa CD40 Ligand Sales Market Share by Type in 2017
    Figure Middle East & Africa CD40 Ligand Sales Market Share by Application in 2017
    Figure Egypt CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Egypt CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure South Africa CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria CD40 Ligand Sales and Growth Rate (2013-2018)
    Figure Nigeria CD40 Ligand Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Biogen, Inc.
    Table CD40 Ligand Introduction of Biogen, Inc.
    Table CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share of Biogen, Inc. (2016-2018)
    Table Industrial Chain of CD40 Ligand
    Table Manufacturing Cost Structure of CD40 Ligand
    Table General Manufacturing Process of CD40 Ligand
    Table Leading Distributors/Dealers of CD40 Ligand
    Table Leading Consumers of CD40 Ligand
    Figure Global CD40 Ligand Sales and Growth Rate Forecast (2018-2028)
    Figure Global CD40 Ligand Revenue and Growth Rate Forecast (2018-2028)
    Table Global CD40 Ligand Market Size and CAGR Forecast by Region (2018-2028)
    Table Global CD40 Ligand Market Size and CAGR Forecast by Type (2018-2028)
    Table Global CD40 Ligand Market Size and CAGR Forecast by Application (2018-2028)
    Table Global CD40 Ligand Market Size and CAGR Forecast by Sales Channel (2018-2028)